TipRanks on MSN
Nasus Pharma initiated with an outperform at Citizens
Citizens initiated coverage of Nasus Pharma (NSRX) with an Outperform rating and $19 price target The firm says the company uses its Nasax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback